XML 37 R27.htm IDEA: XBRL DOCUMENT v3.24.3
COMMITMENTS AND CONTINGENCIES (Tables)
9 Months Ended
Sep. 28, 2024
Commitments and Contingencies Disclosure [Abstract]  
Schedule of Reserve for the Estimated Product Recall Expenses
The following table summarizes the activity of the reserve for the estimated product recall expenses (in thousands):

September 28, 2024
Balance, December 30, 2023
$13,090 
Actual product refunds, replacements and recall-related costs(3,132)
Gift card issuances(1)
(5,935)
Balance, September 28, 2024
$4,023 
_________________________
(1)As of September 28, 2024, we had $3.4 million in unredeemed recall-related gift card liabilities, which are included in contract liabilities within accrued expenses and other current liabilities on our consolidated balance sheet. For the three and nine months ended September 28, 2024, we recognized net sales of $2.7 million and $7.1 million, respectively, from redeemed recall-related gift cards.
Schedule of Recall Reserve Adjustment of Estimated Product Recall Expenses
The product recalls, which include recall reserve adjustments and other incurred costs, had the following effect on our income before income taxes as of the dates indicated (in thousands):

Three Months EndedNine Months Ended
September 28,
2024
September 30,
2023
September 28,
2024
September 30,
2023
Decrease to net sales(1)
$— $(18)$— $(24,524)
Decrease to cost of goods sold(2)
— 843 — 7,148 
Increase (decrease) to gross profit
— 825 — (17,376)
Decrease to SG&A expenses(3)
— — — 10,549 
Increase (decrease) to income before income taxes
$— $825 $— $(6,827)
_________________________
(1)For the three and nine months ended September 30, 2023, primarily reflects the unfavorable impact of the recall reserve adjustment related to higher estimated future recall remedies (i.e., estimated gift card elections). Of the total net sales impact, $8.1 million and $16.4 million was allocated to our DTC and wholesale channels, respectively, for the nine months ended September 30, 2023. These amounts were allocated based on the historical channel sell-in basis of the affected products.
(2)For the three months ended September 30, 2023, reflects a benefit of $0.8 million related to lower than anticipated recall-related costs. For the nine months ended September 30, 2023, reflects favorable impacts of $5.0 million primarily due to the recall reserve adjustment related to lower estimated costs of future product replacement remedy elections and logistics costs, $1.3 million from an inventory reserve adjustment, and $0.8 million related to lower recall-related costs.
(3)For the nine months ended September 30, 2023, reflects the favorable recall reserve adjustment primarily related to lower estimated other recall-related costs.